MARKET

ICCC

ICCC

Immucell
NASDAQ
5.28
0.00
0.00%
Closed 16:00 03/01 EST
OPEN
5.28
PREV CLOSE
5.28
HIGH
5.40
LOW
5.11
VOLUME
6.18K
TURNOVER
0
52 WEEK HIGH
6.23
52 WEEK LOW
4.260
MARKET CAP
40.92M
P/E (TTM)
-7.0834
1D
5D
1M
3M
1Y
5Y
Immucell: Current report
Press release · 5d ago
ImmuCell GAAP EPS of -$0.15, revenue of $5.09M
Seeking Alpha · 5d ago
Earnings Scheduled For February 27, 2024
American Electric Power is expected to report quarterly earnings at $1.26 per share on revenue of $5.12 billion. Gaotu Techedu is likely to report a quarterly loss at $0.07 per share. Other companies reporting before the bell include American Electric Power, Carter's and Sealed Air.
Benzinga · 5d ago
Weekly Report: what happened at ICCC last week (0219-0223)?
Weekly Report · 6d ago
Weekly Report: what happened at ICCC last week (0212-0216)?
Weekly Report · 02/19 11:33
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
ImmuCell Corporation expects to report unaudited financial results for the quarter and year ended December 31, 2023 after the market closes on February 27, 2024. ImmuCell develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle.
Barchart · 02/16 08:30
Weekly Report: what happened at ICCC last week (0205-0209)?
Weekly Report · 02/12 11:22
Weekly Report: what happened at ICCC last week (0129-0202)?
Weekly Report · 02/05 11:31
More
About ICCC
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line, providing Immediate Immunity for the prevention of scours in newborn dairy and beef calves. It expanded this line into four different products with formulations targeting E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. This product line provides Immediate Immunity to newborn calves. The Company is engaged in the development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. The Company’s products reduce the use of traditional antibiotics in food producing animals.

Webull offers ImmuCell Corp stock information, including NASDAQ: ICCC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICCC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICCC stock methods without spending real money on the virtual paper trading platform.